NOVAVAX INC Financing Cash Flow
NOVAVAX INC (NVAX) reported Financing Cash Flow of $38.88 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- NOVAVAX INC net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $1.20M.
- NOVAVAX INC net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $37.67M.
- NOVAVAX INC net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$6.60M.
- NOVAVAX INC net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $42.44M.
- NOVAVAX INC net cash provided by (used in) financing activities for fiscal 2025 was $27.74M, a 89.36% decline from fiscal 2024.
- NOVAVAX INC net cash provided by (used in) financing activities for fiscal 2024 was $260.58M, a 5734.82% increase from fiscal 2023.
- NOVAVAX INC net cash provided by (used in) financing activities for fiscal 2023 was $4.47M, a 98.63% decline from fiscal 2022.
- NOVAVAX INC net cash provided by (used in) financing activities for fiscal 2022 was $324.99M, a 29.61% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $38.88M 10-Q · filed 2026-08-06 | $32.27M derived: sum of 3 quarters · filed 2026-08-06 | $74.71M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $37.67M 10-Q · filed 2026-05-06 | $31.07M derived: sum of 2 quarters · filed 2026-05-06 | $73.51M derived: sum of 3 quarters · filed 2026-05-06 | $72.47M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | -$6.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $35.84M derived: sum of 2 quarters · filed 2026-02-26 | $34.80M derived: sum of 3 quarters · filed 2026-08-06 | $27.74M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $42.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $41.40M derived: sum of 2 quarters · filed 2026-08-06 | $34.34M 10-Q · filed 2025-11-06 | $30.92M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | -$1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$8.10M 10-Q · filed 2026-08-06 | -$11.52M derived: sum of 3 quarters · filed 2026-08-06 | -$11.62M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | -$7.06M 10-Q · filed 2026-05-06 | -$10.48M derived: sum of 2 quarters · filed 2026-05-06 | -$10.58M derived: sum of 3 quarters · filed 2026-05-06 | $247.64M derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | -$3.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$3.52M derived: sum of 2 quarters · filed 2026-02-26 | $254.70M derived: sum of 3 quarters · filed 2026-02-26 | $260.58M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | -$97.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $258.12M derived: sum of 2 quarters · filed 2025-11-06 | $264.00M 10-Q · filed 2025-11-06 | $364.39M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $258.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $264.10M 10-Q · filed 2025-08-06 | $364.49M derived: sum of 3 quarters · filed 2026-02-26 | $561.61M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $5.89M 10-Q · filed 2025-05-08 | $106.28M derived: sum of 2 quarters · filed 2026-02-26 | $303.40M derived: sum of 3 quarters · filed 2026-02-26 | $364.73M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $100.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $297.51M derived: sum of 2 quarters · filed 2026-02-26 | $358.85M derived: sum of 3 quarters · filed 2026-02-26 | $4.47M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | $197.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $258.46M derived: sum of 2 quarters · filed 2024-11-12 | -$95.92M 10-Q · filed 2024-11-12 | $95.52M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $61.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$293.04M 10-Q · filed 2024-08-08 | -$101.60M derived: sum of 3 quarters · filed 2025-02-27 | -$132.58M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | -$354.38M 10-Q · filed 2024-05-10 | -$162.94M derived: sum of 2 quarters · filed 2025-02-27 | -$193.91M derived: sum of 3 quarters · filed 2025-02-27 | -$189.26M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $191.44M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $160.46M derived: sum of 2 quarters · filed 2025-02-27 | $165.12M derived: sum of 3 quarters · filed 2025-02-27 | $324.99M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | -$30.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$26.32M derived: sum of 2 quarters · filed 2023-11-09 | $133.55M 10-Q · filed 2023-11-09 | $72.84M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | $4.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $164.52M 10-Q · filed 2023-08-08 | $103.81M derived: sum of 3 quarters · filed 2024-02-28 | $88.09M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | $159.87M 10-Q · filed 2023-05-09 | $99.15M derived: sum of 2 quarters · filed 2024-02-28 | $83.43M derived: sum of 3 quarters · filed 2024-02-28 | $44.59M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | -$60.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$76.43M derived: sum of 2 quarters · filed 2024-02-28 | -$115.27M derived: sum of 3 quarters · filed 2024-02-28 | $461.71M 10-K · filed 2024-02-28 | ||
| 2021-09-30 | -$15.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$54.56M derived: sum of 2 quarters · filed 2022-11-09 | $522.42M 10-Q · filed 2022-11-09 | $927.03M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-06-30 | -$38.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $538.14M 10-Q · filed 2022-08-09 | $942.75M derived: sum of 3 quarters · filed 2023-02-28 | $920.37M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-03-31 | $576.99M 10-Q · filed 2022-05-10 | $981.60M derived: sum of 2 quarters · filed 2023-02-28 | $959.21M derived: sum of 3 quarters · filed 2023-02-28 | $1.38B derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-12-31 | $404.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $382.22M derived: sum of 2 quarters · filed 2023-02-28 | $798.84M derived: sum of 3 quarters · filed 2023-02-28 | $984.76M 10-K · filed 2023-02-28 | ||
| 2020-09-30 | -$22.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $394.23M derived: sum of 2 quarters · filed 2021-11-05 | $580.15M 10-Q · filed 2021-11-05 | $610.32M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | $416.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $602.54M 10-Q · filed 2021-08-05 | $632.71M derived: sum of 3 quarters · filed 2022-03-01 | $644.74M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | $185.92M 10-Q · filed 2021-05-10 | $216.09M derived: sum of 2 quarters · filed 2022-03-01 | $228.12M derived: sum of 3 quarters · filed 2022-03-01 | $228.13M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $30.17M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $42.20M derived: sum of 2 quarters · filed 2022-03-01 | $42.20M derived: sum of 3 quarters · filed 2022-03-01 | $98.38M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $12.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $12.03M derived: sum of 2 quarters · filed 2020-11-10 | $68.21M 10-Q · filed 2020-11-10 | $72.07M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $56.18M 10-Q · filed 2020-08-10 | $60.04M derived: sum of 3 quarters · filed 2021-03-01 | $61.06M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-03-31 | $56.18M 10-Q · filed 2020-05-11 | $60.04M derived: sum of 2 quarters · filed 2021-03-01 | $61.06M derived: sum of 3 quarters · filed 2021-03-01 | $115.06M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $3.86M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $4.88M derived: sum of 2 quarters · filed 2021-03-01 | $58.88M derived: sum of 3 quarters · filed 2021-03-01 | $102.81M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $55.02M derived: sum of 2 quarters · filed 2019-11-07 | $98.95M 10-Q · filed 2019-11-07 | $116.36M derived: sum of 4 quarters · filed 2020-03-11 | ||
| 2018-06-30 | $54.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $97.93M 10-Q · filed 2019-08-07 | $115.34M derived: sum of 3 quarters · filed 2020-03-11 | $138.97M derived: sum of 4 quarters · filed 2020-03-11 | ||
| 2018-03-31 | $43.92M 10-Q · filed 2019-05-02 | $61.34M derived: sum of 2 quarters · filed 2020-03-11 | $84.97M derived: sum of 3 quarters · filed 2020-03-11 | $93.10M derived: sum of 4 quarters · filed 2020-03-11 | ||
| 2017-12-31 | $17.41M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $41.05M derived: sum of 2 quarters · filed 2020-03-11 | $49.18M derived: sum of 3 quarters · filed 2020-03-11 | $64.54M 10-K · filed 2020-03-11 | ||
| 2017-09-30 | $23.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $31.76M derived: sum of 2 quarters · filed 2018-11-07 | $47.13M 10-Q · filed 2018-11-07 | $47.89M derived: sum of 4 quarters · filed 2019-03-18 | ||
| 2017-06-30 | $8.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $23.50M 10-Q · filed 2018-08-08 | $24.26M derived: sum of 3 quarters · filed 2019-03-18 | |||
| 2017-03-31 | $15.36M 10-Q · filed 2018-05-09 | $16.13M derived: sum of 2 quarters · filed 2019-03-18 | ||||
| 2016-12-31 | $765.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $279.85M 10-K · filed 2019-03-18 | $279.03M 10-K · filed 2018-03-14 | |||
| 2016-09-30 | $279.08M 10-Q · filed 2017-11-07 | |||||
| 2015-12-31 | $208.28M 10-K · filed 2018-03-14 | |||||
| 2014-03-31 | $1.17M 10-Q · filed 2014-05-08 | |||||
| 2013-09-30 | $119.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $123.76M derived: sum of 2 quarters · filed 2013-11-12 | $130.94M 10-Q · filed 2013-11-12 | $157.97M derived: sum of 4 quarters · filed 2014-05-08 | ||
| 2013-06-30 | $4.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $11.57M 10-Q · filed 2013-08-08 | $38.60M derived: sum of 3 quarters · filed 2014-05-08 | $45.98M derived: sum of 4 quarters · filed 2014-05-08 | ||
| 2013-03-31 | $7.18M 10-Q · filed 2014-05-08 | $34.21M derived: sum of 2 quarters · filed 2014-05-08 | $41.59M derived: sum of 3 quarters · filed 2014-05-08 | $53.71M derived: sum of 4 quarters · filed 2014-05-08 | ||
| 2012-12-31 | $27.03M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $34.41M derived: sum of 2 quarters · filed 2013-11-12 | $46.53M derived: sum of 3 quarters · filed 2013-11-12 | $53.79M 10-K · filed 2013-03-12 | ||
| 2012-09-30 | $7.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $19.50M derived: sum of 2 quarters · filed 2013-11-12 | $26.76M 10-Q · filed 2013-11-12 | $25.92M 10-Q · filed 2012-11-09 | $28.61M derived: sum of 4 quarters · filed 2013-11-12 | |
| 2012-06-30 | $12.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $19.37M 10-Q · filed 2013-08-08 | $21.23M derived: sum of 3 quarters · filed 2013-08-08 | $22.15M derived: sum of 4 quarters · filed 2013-08-08 | ||
| 2012-03-31 | $7.26M 10-Q · filed 2013-05-09 | $9.11M derived: sum of 2 quarters · filed 2013-05-09 | $10.03M derived: sum of 3 quarters · filed 2013-05-09 | $17.04M derived: sum of 4 quarters · filed 2013-05-09 | ||
| 2011-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $2.77M derived: sum of 2 quarters · filed 2013-03-12 | $9.78M derived: sum of 3 quarters · filed 2013-03-12 | $11.13M 10-K · filed 2013-03-12 | ||
| 2011-09-30 | $923.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $7.92M derived: sum of 2 quarters · filed 2012-11-09 | $9.28M 10-Q · filed 2012-11-09 | $10.24M derived: sum of 4 quarters · filed 2013-03-12 | ||
| 2011-06-30 | $7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $8.36M 10-Q · filed 2012-08-09 | $9.31M derived: sum of 3 quarters · filed 2013-03-12 | $28.36M derived: sum of 4 quarters · filed 2013-03-12 | ||
| 2011-03-31 | $1.35M 10-Q · filed 2012-05-09 | $2.31M derived: sum of 2 quarters · filed 2013-03-12 | $21.36M derived: sum of 3 quarters · filed 2013-03-12 | |||
| 2010-12-31 | $958.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $20.00M derived: sum of 2 quarters · filed 2013-03-12 | $23.43M 10-K · filed 2013-03-12 | |||
| 2010-09-30 | $19.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $22.47M 10-Q · filed 2011-11-08 | ||||
| 2010-06-30 | $3.43M 10-Q · filed 2011-08-09 | |||||
| 2009-12-31 | $42.29M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |